---
$id: https://graph.org.ai/products/commodity/51143204
$type: Product
source: UNSPSC
code: "51143204"
title: "Acamprosate"
class: "51143200"
classTitle: "Anti abuse drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Acamprosate

**UNSPSC Code**: 51143204
**Class**: [Anti abuse drugs](Anti abuse drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N4K14YGM3J. European Medicines Agency schedules Acamprosate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07366MIG. Acamprosate generally arises in the molecular formula C5H11NO4S. The term ACAMPROSATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, no. 3 1990, list 30.) ACAMPROSATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acamprosate under HS 29241900 and SITC 51471. As of Q4 2014, ACAMPROSATE remains the US FDA Preferred Term for this commodity. Acamprosate bears US NLM identifiers UMLS ID C0284941 and NCI Concept Code C81691. SMILES: S(=O)(=O)(O)CCCNC(=O)C.

